THE RISK ASSOCIATED WITH CORNEAL TRANSPLANTATION FROM DONORS WITH CANCER: WORTH THE GAMBLE?

Abstract

Our fragmented understanding of cancer biology limits the early detection of benign growths and metastases to other sites. Here, we discuss recent studies illustrating the need to further refine the screen for the detection of metastases and experimental studies to aid our understanding of the effects of completed chemotherapy on the potential transplant.